文献速递呼吸道感染肺栓塞与肺血管病呼吸危重症与机械通气

重型COVID-19肺炎的肺血管病变:生理、影像与血液学观察

Pulmonary Angiopathy in Severe COVID-19: Physiologic, Imaging, and Hematologic Observations.
PubMed 文献 · Am J Respir Crit Care Med · 2020-01-01

研究纳入39例重型COVID-19肺炎患者,结合CT肺血管造影、双能CT灌注成像与血栓弹力图评估肺损伤的生理、影像与血液学基础。结果显示患者存在显著肺灌注异常、生理死腔增加、高凝状态及纤溶抑制,提示肺血管病变与血栓形成导致肺灌注受损。

要点

  • 重型COVID-19肺炎患者存在明显肺灌注异常与生理死腔增加。
  • 血栓弹力图提示高凝状态伴纤溶抑制。
  • 双能CT灌注缺损普遍存在,部分患者无急性肺栓塞证据。

核心结论

  • 重型COVID-19肺炎不仅存在高凝表型,还存在肺血管病变与血栓形成所致的显著肺灌注受损。

研究设计与样本

  • 研究汇总39例连续重型COVID-19肺炎患者的临床、生理与实验室数据,评估CT肺血管造影(n=39)与双能CT(n=20)影像,并用血栓弹力图评估凝血状态。

主要发现

  • 患者动态顺应性33.7±14.7 ml/cm H2O,Murray肺损伤评分3.14±0.53,平均通气比2.6±0.8。
  • CT示正常通气肺、磨玻璃影与致密实变的平均范围分别为23.5±16.7%、36.3±24.7%、42.7±27.1%。
  • 至少两个可评估肺叶的患者中21/33(63.6%)存在外周血管扩张,其中10/21(47.6%)无急性肺栓塞证据。
  • 双能CT可评估18/20(90%),全部患者存在灌注缺损(楔形3例、斑片状9例、混合型6例)。

临床怎么用

  • 对重型COVID-19肺炎应关注肺灌注异常与高凝状态,警惕肺血管病变参与低氧与死腔增加。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Clinical and epidemiologic data in coronavirus disease (COVID-19) have accrued rapidly since the outbreak, but few address the underlying pathophysiology.Objectives: To ascertain the physiologic, hematologic, and imaging basis of lung injury in severe COVID-19 pneumonia.Methods: Clinical, physiologic, and laboratory data were collated. Radiologic (computed tomography (CT) pulmonary angiography [n = 39] and dual-energy CT [DECT, n = 20]) studies were evaluated: observers quantified CT patterns (including the extent of abnormal lung and the presence and extent of dilated peripheral vessels) and perfusion defects on DECT. Coagulation status was assessed using thromboelastography.Measurements and Results: In 39 consecutive patients (male:female, 32:7; mean age, 53 ± 10 yr [range, 29-79 yr]; Black and minority ethnic, n = 25 [64%]), there was a significant vascular perfusion abnormality and increased physiologic dead space (dynamic compliance, 33.7 ± 14.7 ml/cm H2O; Murray lung injury score, 3.14 ± 0.53; mean ventilatory ratios, 2.6 ± 0.8) with evidence of hypercoagulability and fibrinolytic "shutdown". The mean CT extent (±SD) of normally aerated lung, ground-glass opacification, and dense parenchymal opacification were 23.5 ± 16.7%, 36.3 ± 24.7%, and 42.7 ± 27.1%, respectively. Dilated peripheral vessels were present in 21/33 (63.6%) patients with at least two assessable lobes (including 10/21 [47.6%] with no evidence of acute pulmonary emboli). Perfusion defects on DECT (assessable in 18/20 [90%]) were present in all patients (wedge-shaped, n = 3; mottled, n = 9; mixed pattern, n = 6).Conclusions: Physiologic, hematologic, and imaging data show not only the presence of a hypercoagulable phenotype in severe COVID-19 pneumonia but also markedly impaired pulmonary perfusion likely caused by pulmonary angiopathy and thrombosis.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Patel BV, Arachchillage DJ, Ridge CA, et al. Pulmonary Angiopathy in Severe COVID-19: Physiologic, Imaging, and Hematologic Observations. Am J Respir Crit Care Med. 2020. PMID: 32667207. doi:10.1164/rccm.202004-1412OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。